Table 1.
Hepatocellular Carcinoma† | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | ||
Hepatocellular carcinoma, nonmicroscopic (%) | 38 | 39 | 42 | 46 | 53 | 57 | 71 | 67 | 74 | P = .001** |
Hepatocellular carcinoma, microscopic (%) | 42 | 38 | 41 | 40 | 28 | 29 | 24 | 19 | 20 | |
Hepatocellular carcinoma, other* (%) | 20 | 22 | 18 | 14 | 19 | 14 | 5 | 15 | 5 | |
Pancreatic Cancer† | ||||||||||
1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | ||
Pancreatic cancer, nonmicroscopic (%) | 61 | 56 | 56 | 57 | 56 | 56 | 56 | 48 | 54 | P = .05** |
Pancreatic cancer, microscopic (%) | 21 | 29 | 41 | 40 | 38 | 34 | 42 | 47 | 41 | |
Pancreatic cancer, other* (%) | 18 | 15 | 3 | 4 | 6 | 10 | 2 | 5 | 5 | |
Brain Cancer† | ||||||||||
1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | ||
Brain cancer, nonmicroscopic (%) | 14 | 9 | 13 | 8 | 9.9 | 8 | 5 | 6 | 7 | P = .80 |
Brain cancer, microscopic (%) | 59 | 69 | 63 | 68 | 63 | 61 | 68 | 66 | 67 | |
Brain cancer, other* (%) | 27 | 22 | 25 | 24 | 28 | 31 | 27 | 28 | 27 | |
Lung Cancer† | ||||||||||
1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | ||
Lung cancer, nonmicroscopic (%) | 10 | 11 | 8 | 8 | 6 | 6 | 9 | 6 | 5 | P = .01** |
Lung cancer, microscopic (%) | 76 | 79 | 85 | 87 | 90 | 86 | 85 | 87 | 86 | |
Lung cancer, other* (%) | 14 | 10 | 7 | 5 | 4 | 8 | 6 | 8 | 8 |
Other includes those with diagnosis of death certificate or unknown.
Statistically significant.
χ2 test for trend was conducted on microscopic diagnosis versus all others.